Shenzhen Mindray Bio-Medic-A

13F holders, Q1 2024 (March 31)
1holders
$38.55avg. 13F price*

At the end of Q1 2024, 1 institutions reported holding Shenzhen Mindray Bio-Medic-A in their 13F filings. The largest holder was Boston Common Asset Management, LLC ($4.6M).

Company
Shenzhen Mindray Bio-Medic-A
CUSIP
Y774E3101
Latest filing quarter
Q3 2025

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025

Total Exit/New Position Q1 2024

No earlier quarter to compare with.

Ownership 1 holders

Boston Common Asset Management, LLC 0.11% Add +2.8% 119,354 $4.6M

"% of holder's portfolio" is SHENZHEN MINDRAY BIO-MEDIC-A's weight in each manager's 13F, not the share of Shenzhen Mindray Bio-Medic-A the manager owns.